01-03-2008: 454 Life Sciences, a part of Roche Applied Science, announced that researchers from the Istituto Agrario San Michele all'Adige and Myriad Genetics have used the company's first generation instrument, the Genome Sequencer 20 System, to sequence and assemble the genome of the grape species Pinot Noir Noir. 454 Sequence data was used in conjunction with Sanger data to produce an assembled genome of 477 million bases in length with 29,585 predicted genes. The study appeared in the journal PLoS ONE.
Pinot Noir is a red wine grape from the species Vitis vinifera and is one of the most popular varietals in the world. The red grape is chiefly associated with the Burgundy region of France, but is also widely grown in many regions throughout the world. The Grapevine Genome Initiative was established with the aim of accelerating the breeding of this difficult perennial species. The Pinot Noir genome sequence will aid growers breed grapes for resistance against aggressive micro-organisms, which are currently controlled by massive use of agrochemicals, without altering wine quality.
The Pinot noir genome was assembled into 2,093 metacontigs which spanned 477.1 million nucleotides, anchored to 19 linkage groups. 29,585 genes were predicted from the sequence with many candidate genes implicated in traits relevant to grapevine cultivation such as those influencing wine quality and those connected with susceptibility to grape pathogens. approximately 2,000,000 Single Nucleotide Polymorphisms (SNPs) were identified with one or more SNPs detected in 87% of genes. Furthermore, the study describes the genome content in repeats and transposons, miRNAs, tRNAs, snRNAs, rRNAs, snoRNAs, and transcription factor genes.
A team of researchers from Roche, including scientists from Roche Pharma Research and Early Development and Roche NimbleGen, reported in Genome Research that they have generated the first draft genome sequence of the cynomolgus monkey (Macaca fascicularis) and developed a novel microarray d ... more
The xCELLigence RTCA System of Roche is being used in the European Union’s DETECTIVE ("Detection of endpoints and biomarkers for repeated dose toxicity using in vitro systems”) Project, a joint study funded by the European Cosmetics Association (Colipa) and the European Commission, where Ro ... more
The deadly E. coli O104 strain that has killed dozens and hospitalized thousands across Europe has been sequenced using 454 Life Sciences’ benchtop GS Junior sequencing system to generate the “most accurate and detailed genetic analysis to date” of this particularly virulent strain. The seq ... more
The main focus in proteomic studies is on the identification of proteins in given biological samples. Proteins isolated and separated from a given sample (e.g., whole cell lysates, blood or tissue, protein complexes) by immunoprecipitation or affinity chromatography or two-dimensional elect ... more
Transfection of cells is one of the main techniques used to influence gene expression. Most primary cells and human skeletal myoblasts (SkMC) in particular are very difficult to transfect, whereas for cell lines such as C2C12, many suitable transfection reagents and protocols are available. ... more
One of the most interesting aspects of real-time PCR based on detection of fluorophoric-labeled oligonucleotides, such as Hydrolysis probes, and Molecular Beacons, is the possibility of being able to detect conveniently multiple targets in the same PCR reaction (multiplex PCR). Ideally, a ... more
At Roche, about 80,000 people across 150 countries are pushing back the frontiers of healthcare.
Working together, we’ve become one of the world’s leading research-focused healthcare
groups. Our success is built on innovation, curiosity and diversity, and on seeing each other’s differences ... more
Roche announced that the US Food and Drug Administration (FDA) has approved the cobas HPV (Human Papillomavirus) Test which identifies women at highest risk for developing cervical cancer. This test will help physicians make early, more accurate decisions about patient care, which may preve ... more
Roche and IBM announced an agreement to develop a nanopore-based sequencer that will directly read and decode human DNA quickly and efficiently. Focused on advancing IBM’s recently published “DNA Transistor” technology, the collaboration will take advantage of IBM’s leadership in microelect ... more
caprotec bioanalytics GmbH announced that it has successfully completed a research collaboration with F. Hoffmann-La Roche, Basel, Switzerland. Under the collaboration research agreement, caprotec used its proprietary CCMS (Capture Compound Mass Spectrometry) technology to analyze the bindi ... more
The deadly E. coli O104 strain that has killed dozens and hospitalized thousands across Europe has been sequenced using 454 Life Sciences’ benchtop GS Junior sequencing system to generate the “most accurate and detailed genetic analysis to date” of this particularly virulent strain. The seq ... more
454 Life Sciences, a Roche company, and Roche NimbleGen, both units of Roche Applied Science, have announced a collaboration with Eli Lilly and Company and SeqWright. The goal of this collaboration is to use genomic technologies to identify genetic variants possibly associated with various ... more
For many years, researchers at the Alfred Wegener Institute (AWI) for Polar and Marine Research in Bremerhaven, Germany have been studying polar and marine environments to improve our understanding of ocean-ice-atmosphere interactions and the animal and plant kingdoms of the Arctic and Anta ... more